[HTML][HTML] Role of protein-bound carbonyl groups in the formation of advanced glycation endproducts

J Liggins, AJ Furth - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 1997 - Elsevier
J Liggins, AJ Furth
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1997Elsevier
Several mechanisms have been postulated for the formation of advanced glycation
endproducts (AGEs) from glycated proteins; they all feature protein-bound carbonyl
intermediates. Using 2, 4-dinitrophenylhydrazine (DNPH), we have detected these
intermediates on bovine serum albumin, lysozyme and β-lactoglobulin after in vitro glycation
by glucose or fructose. Carbonyls were formed in parallel with AGE-fluorophores, via
oxidative Maillard reactions. Neither Amadori nor Heyns products contributed to the DNPH …
Several mechanisms have been postulated for the formation of advanced glycation endproducts (AGEs) from glycated proteins; they all feature protein-bound carbonyl intermediates. Using 2,4-dinitrophenylhydrazine (DNPH), we have detected these intermediates on bovine serum albumin, lysozyme and β-lactoglobulin after in vitro glycation by glucose or fructose. Carbonyls were formed in parallel with AGE-fluorophores, via oxidative Maillard reactions. Neither Amadori nor Heyns products contributed to the DNPH reaction. Fluorophore and carbonyl yields were much enhanced in lipid-associated proteins, but both groups could also be detected in lipid-free proteins. When pre-glycated proteins were incubated in the absence of free sugar, carbonyl groups were rapidly lost in a first-order reaction, while fluorescence continued to develop beyond the 21 days of incubation. Another unexpected finding was that not all carbonyl groups were blocked by aminoguanidine, although there was complete inhibition of reactions leading to AGE-fluorescence. It is suggested that carbonyls acting as fluorophore precursors react readily with aminoguanidine, while others are resistant to this hydrazine, possibly because they are involved in ring closure. Factors influencing the relative rates of acyclisation and hydrazone formation are discussed, together with possible implications for antiglycation therapy.
Elsevier